ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1851

Improving Walking Ability in Degenerative Lumbar Spinal Stenosis: A Randomized Trial Comparing 2 Self-Management Training Programs

Carlo Ammendolia1, Pierre Côté2, Danielle Southerst3, Michael Schneider4, Brian Budgell3, Claire Bombardier5, Gillian Hawker6 and Y. Raja Rampersaud7, 1Surgery, University of Toronto, Toronto, ON, Canada, 2University of Ontario Institute of Technology, Toronto, ON, Canada, 3Canadian Memorial Chiropractic College, Toronto, ON, Canada, 4University of Pittsburgh, Pittsburgh, PA, 5Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 6Professor, Full SGS Member Department of Medicine, University of Toronto Chief of Medicine, Women's College Hospital 76 Grenville Street 8th Floor East, Room 815, University of Toronto, Toronto, ON, Canada, 7University of Toronto, Toronto, ON, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Disability, Neurologic involvement, osteoarthritis and spine involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: ACR/ARHP Combined: Orthopedics and Rehabilitation Science

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Degenerative lumbar spinal stenosis (DLSS) is a leading cause of pain, disability and loss of independence in older adults. It is caused by age related osteoarthritic changes to the lumbar spine resulting in spinal canal narrowing and compression to the spinal nerves. Neurogenic claudication is the clinical syndrome caused by DLSS and reduced walking ability is its hallmark feature. Effective non-surgical approaches for DLSS are unknown. The main objective of this study is to compare the ability of 2 self-management training programs to improve walking capacity in DLSS.

Methods: Eligible consenting participants with neurogenic claudication with DLSS and limited walking ability (<30 minutes) were randomized to a 6-week (w) comprehensive self-management training program or a self-directed self-management training program with a single educational session. Both groups received a pedometer, an exercise manual and video with instructions on daily home exercises and self-management strategies recommended to be followed for life. The primary outcomes were objective continuous walking distance in meters (m) in 30 minutes assessed by the Self-Paced Walk Test (SPWT) at 8w, 3, 6 and 12 months following randomization; and the proportion of participants achieving at least 30% improvement (minimal clinically important difference, MCID) in the SPWT. Secondary outcomes included the Zurich Claudication Questionnaire (ZCQ), the Oswestry Disability Index and the Numeric Pain Scale for low back and leg pain. Intention-to-treat analysis was performed for all outcomes.

Results: Fifty-one participants were randomized to the comprehensive and 53 to the self-directed group. At 8w, the mean improvement in walking distance was 502m in the comprehensive group and 211m in the self-directed group, with an adjusted mean treatment effect of 345.4m; 95% confidence interval [CI], 150 to 660.6; P=0.0006. At 12 months the mean improvement in walking distance from baseline was 675m in the comprehensive group and 201m in the self-directed group with a between-group adjusted mean difference of 473.2m; 95% CI, 203.9 to 742.4; P = 0.0007. At 8w, 85% verses 61%, adjusted relative risk (RR), 1.4; 95% CI, 1.1 to 1.8; P= 0.008, and at 12 months, 81% verses 59%, adjusted RR, 1.4; 95% CI, 1.1 to 1.8; P= 0.018, of participants achieved the MCID in the SPWT in the comprehensive verses the self-directed group respectively. At 12 months all secondary outcomes showed significant improvement from baseline in both groups with the comprehensive group demonstrating significantly greater improvement in the ZCQ functional scale, adjusted mean difference of -0.27; 95% CI, -0.49 to -0.04, and in the combined functional and symptom ZCQ scale, adjusted mean difference of -0.48; 95% CI, -0.90 to -0.06 compared to the self-directed group.

Conclusion: Both self-management training programs showed significant improvement in walking distance with the comprehensive program demonstrating superior improvement in walking distance and proportion of participants meeting the MCID at each follow-up. The large improvement in walking distance in comprehensive group was sustained at 12 months without additional interventions beyond the initial comprehensive training program.


Disclosure: C. Ammendolia, None; P. Côté, None; D. Southerst, None; M. Schneider, None; B. Budgell, None; C. Bombardier, None; G. Hawker, None; Y. R. Rampersaud, None.

To cite this abstract in AMA style:

Ammendolia C, Côté P, Southerst D, Schneider M, Budgell B, Bombardier C, Hawker G, Rampersaud YR. Improving Walking Ability in Degenerative Lumbar Spinal Stenosis: A Randomized Trial Comparing 2 Self-Management Training Programs [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/improving-walking-ability-in-degenerative-lumbar-spinal-stenosis-a-randomized-trial-comparing-2-self-management-training-programs/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-walking-ability-in-degenerative-lumbar-spinal-stenosis-a-randomized-trial-comparing-2-self-management-training-programs/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology